Ep#025: Leveraging Real World Data for Effective Treatment of Multiple Sclerosis with Dr. Richard Rudick

Personalized Medicine Podcast

In this episode we talk about multiple sclerosis (MS) and the role personalized medicine and real world data (RWD) are playing in treating this disease effectively. To discuss this topic, we sat down with one of the leading experts in this field - Dr. Rick Rudick. Rick is a neurologist by training and has more than 25 years of experience at Cleveland Clinic where he developed and directed the Mellen Center for Multiple Sclerosis. Rick was also a Vice President of pharmaceutical company Biogen, where he developed the Multiple Sclerosis Innovation Hub and was involved in establishing international Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) program. With about 250 peer-reviewed publications, Rick is one of the most cited researchers in the field.
Together with Rick we discussed:
◦ Disease-modifying therapeutics for MS
◦ Role of RWD & RWE in determining most efficient treatment for MS
◦ Establishment of world’s largest learning health system for MS (MS PATHS)
◦ Role of international cooperation in standardizing patient care
◦ Challenges in collection and processing of diverse patient data
◦ Role of MRI in MS diagnostics
◦ Translation of novel diagnostic approaches from research to clinics
◦ The future of therapeutics for neurological diseases
Get in touch with Rick:
◦ LinkedIn: https://www.linkedin.com/in/richard-rudick-966501a5/
◦ Web (MS-PATHS program): https://www.mspaths.com/
Make sure to download the full show notes with our guest's bio, links to their most notable work, and our recommendations for further reads on the topic of the episode at pmedcast.com